CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology Long-Term Outcomes in Women and Men Following Percutaneous Coronary Intervention The spectrum of chronic coronary syndromes: genetics, imaging, and management after PCI and CABG Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial Randomized Comparison of Everolimus- and Zotarolimus-Eluting Coronary Stents With Biolimus-Eluting Stents in All-Comer Patients Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial The Elusive Late Benefit of Biodegradable Polymer Drug-Eluting Stents

Original Research2018 Apr 9;11(7):665-674.

JOURNAL:JACC Cardiovasc Interv. Article Link

Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost

Kwok CS, Rao SV, Potts JE et al. Keywords: cost; percutaneous coronary intervention; predictors; readmission

FULL TEXT PDF